We are live on ! Find out more
ICM

Invenomic Capital Management Portfolio holdings

AUM $2.18B
1-Year Est. Return 0.03%
This Fund
S&P 500
This Quarter Est. Return
-4.09%
1 Year Est. Return
+0.03%
3 Year Est. Return
-6.37%
5 Year Est. Return
-25.27%
10 Year Est. Return
AUM
$468M
AUM Growth
+$160M
Cap. Flow
+$174M
Cap. Flow %
37.12%
Top 10 Hldgs %
25.86%
Holding
170
New
51
Increased
61
Reduced
22
Closed
28

Top Sells

Rank Stock Value
1
DLTR icon
Dollar Tree
DLTR
+$5M
2
CIVI
Civitas Resources
CIVI
+$4.58M
3
BABA icon
Alibaba
BABA
+$4.31M
4
CNC icon
Centene
CNC
+$4.16M
5
PRU icon
Prudential Financial
PRU
+$3.94M

Sector Composition

Rank Sector Weight
1 Technology 14.78%
2 Consumer Discretionary 12.04%
3 Healthcare 11.59%
4 Financials 10.04%
5 Materials 9.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FISV
51
Fiserv Inc
FISV
$28.1B
$3.54M 0.76%
+34,138
New +$3.53M
NRDY icon
52
Nerdy
NRDY
$94.9M
$3.44M 0.73%
+763,494
New +$5.45M
OXY icon
53
Occidental Petroleum
OXY
$58.1B
$3.11M 0.67%
+107,434
New +$3.37M
SENEA icon
54
Seneca Foods Class A
SENEA
$1.2B
$3M 0.64%
62,446
+17,675
+39% +$870K
GDXJ icon
55
VanEck Junior Gold Miners ETF
GDXJ
$8.31B
$2.94M 0.63%
70,195
PSX icon
56
Phillips 66
PSX
$83.9B
$2.7M 0.58%
+37,214
New +$2.81M
KGC icon
57
CALL
Kinross Gold
KGC
$32.1B
$2.67M 0.57%
+460,000
New +$2.75M
SNEX icon
58
StoneX
SNEX
$8.06B
$2.5M 0.53%
+206,606
New +$2.71M
DMC
59
Del Monte Corp
DMC
$1.42B
$2.5M 0.53%
+90,562
New +$2.67M
SBH icon
60
Sally Beauty Holdings
SBH
$1.55B
$2.45M 0.52%
132,743
+39,221
+42% +$715K
ADEA icon
61
Adeia
ADEA
$3.12B
$2.4M 0.51%
479,931
+85,250
+22% +$425K
UHS icon
62
Universal Health Services
UHS
$10.5B
$2.38M 0.51%
+18,324
New +$2.36M
AAWW
63
DELISTED
Atlas Air Worldwide Holdings, Inc.
AAWW
$2.27M 0.49%
24,142
-10,276
-30% -$885K
TAP icon
64
Molson Coors Class B
TAP
$7.83B
$2.23M 0.48%
48,093
+966
+2% +$44.3K
GAP
65
The Gap Inc
GAP
$7.51B
$2.2M 0.47%
+124,459
New +$2.61M
HBB icon
66
Hamilton Beach Brands
HBB
$427M
$2.18M 0.47%
151,977
+22,985
+18% +$354K
PRU icon
67
Prudential Financial
PRU
$41.8B
$2.16M 0.46%
19,955
-36,323
-65% -$3.94M
CNVY
68
DELISTED
Convey Health Solutions Holdings, Inc.
CNVY
$2.15M 0.46%
+256,951
New +$1.89M
SLCA
69
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
$2.14M 0.46%
227,533
-81,327
-26% -$810K
STRA icon
70
Strategic Education
STRA
$1.9B
$2.12M 0.45%
+36,634
New +$2.3M
TRST
71
Trustco Bank Corp NY
TRST
$940M
$2.1M 0.45%
63,158
+13,527
+27% +$449K
VHI icon
72
Valhi
VHI
$473M
$2.01M 0.43%
69,814
-12,307
-15% -$315K
LYB icon
73
LyondellBasell Industries
LYB
$19.7B
$1.92M 0.41%
+20,777
New +$1.93M
PRTH icon
74
Priority Technology Holdings
PRTH
$439M
$1.9M 0.41%
268,907
+22,416
+9% +$138K
CNR
75
DELISTED
Cornerstone Building Brands, Inc.
CNR
$1.9M 0.41%
108,816
-28,437
-21% -$442K

Similar funds

Invenomic Capital Management's Q4 2021 Portfolio in Review

As of Q4 2021, Invenomic Capital Management held 170 positions worth $468M, up 52% from $308M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Invenomic Capital Management deployed $174M of net new capital in Q4 2021, opening 51 new positions and adding to 61 existing holdings. Its largest new stake was AT&T: 626,014 shares worth $11.6M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 7.4% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Civitas Resources, an estimated $4.58M trimmed.

  • Invenomic Capital Management's largest Q4 2021 buy was AT&T: 626,014 shares worth $11.6M.
  • Invenomic Capital Management added most to Cigna in Q4 2021, an estimated $5.95M increase.
  • Invenomic Capital Management's biggest Q4 2021 reduction was Civitas Resources, cutting an estimated $4.58M.
  • Invenomic Capital Management fully exited Dollar Tree in Q4 2021, selling an estimated $5M.
  • Invenomic Capital Management's ten largest holdings make up 26% of its $468M portfolio in Q4 2021.
  • Invenomic Capital Management opened 51 new positions and closed 28 in Q4 2021.
  • Invenomic Capital Management's portfolio value rose 52% quarter-over-quarter to $468M.

Based on Invenomic Capital Management's 13F filing for Q4 2021, filed 11 Feb 2022.